ArticleCurrent medical imaging2025
Adult Bronchial Inflammatory Myofibroblastic Tumor: A Case Report.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionInflammatory myofibroblastic tumor (IMT) is a neoplasm originating from mesenchymal tissue and can occur in multiple parts of the body, such as the lungs, abdomen, pelvis, and retroperitoneum. Although the lung is a relatively common site for IMT, airway involvement in adults is rare, and most reported cases involve the central airway. Reports of IMT arising within the bronchus are uncommon. CASE PRESENTATION: We, herein, report the case of a 72-year-old male patient with bronchial IMT who was admitted due to a recurrent cough that worsened over two weeks. Tumor markers showed no significant elevation, and imaging examinations suggested a tumor in the left upper lobe bronchus. Due to the suspicion of malignancy, the patient underwent thoracoscopic left upper lobectomy. Postoperative pathological examination revealed an inflammatory myxoid myofibroblastic tumor of the left upper lobe bronchus. During a 12-month postoperative follow-up, no significant signs of metastasis or recurrence were observed.
conclusionWe have reported the case of endobronchial IMT in an adult, with a degree of contrast enhancement on CT lower than that previously reported for intratracheal IMT. The tumor lacks specific clinical symptoms and laboratory findings, which poses a challenge for accurate and timely preoperative diagnosis. Based on literature reports, in patients with recurrent cough, hemoptysis, or dyspnea, if CT shows a smoothly marginated endobronchial nodule with mild enhancement, the possibility of this disease should be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.